Patients with oligometastasis and favorable or intermediate-risk disease benefit the most.
-
-
The latest stories you need to know.
-
Findings from a phase 1/2 trial.
-
US states with larger screening declines have larger incidence increases.
-
The combination is well tolerated and warrants further prospective evaluation.
-
The latest stories you need to know.
-
COVID-19 vaccination coverage in care homes may have a major role in the decision.
-
Exploratory analysis of STAMPEDE trial.
-
Public expectations about the likelihood of easing restrictions need to be carefully managed, European Centre for Disease Prevention and Control cautions.
-
Should children be vaccinated earlier for HPV?
-
The latest stories you need to know.
-
COVID-19 Around the world weekly highlights: cases down, variants up, mixed success with vaccine rollout...
-
With misinformation casting a shadow over COVID-19 vaccine uptake, experts debate the issue.
-
FDA granted accelerated approval to enfortumab vedotin based on phase 2 results.